Several studies have been conducted on the effects of using Januvia® (
sitagliptin) to treat type 2 diabetes. In one study, people taking this drug lowered their HbA1c (a test used to measure long-term blood sugar control) by 0.6 percent on average. In other studies, Januvia lowered fasting blood sugar by 13 mg/dL on average. It also lowered postprandial blood sugar (blood sugar after a meal) by 49 mg/dL on average.
Januvia affects the body by slowing down the breakdown of incretin hormones, increasing the level of these hormones in the body. It is this increase in incretin hormones that is responsible for Januvia's beneficial effects, including increasing insulin production in response to meals and decreasing the amount of glucose (sugar) that the liver produces.
(Click Januvia to learn more about the effects of this medication. This article also offers tips on when and how to take your dosage, and lists safety issues to be aware of before starting treatment.)
HealthSavvy Sign In
|